Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universita' Degli Studi Di Torino
Sponsor

Universita' Degli Studi Di Torino

Italy Corso Bramante 88/90, 10126 Turin, Italy

About the sponsor

Multiple myeloma is a major area of interest, with studies spanning newly diagnosed disease in patients eligible for autologous stem cell transplantation and in older or transplant-ineligible populations.

  • Induction and maintenance strategies in newly diagnosed multiple myeloma
  • Treatment approaches for transplant-ineligible myeloma
  • Response and progression control in plasma cell disorders

Research activity in this area includes combinations built around proteasome inhibitors, immunomodulatory agents, and anti-CD38 therapy.

About Specializations

Universita' Degli Studi Di Torino runs clinical trials in conditions such as Plasma cell myeloma, Prostate cancer metastatic, Critical illness, Malignant pleural effusion, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Prostate cancer metastatic

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Universita' Degli Studi Di Torino

Critical illness

Recruiting
Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Universita' Degli Studi Di Torino

Malignant pleural effusion

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Universita' Degli Studi Di Torino

Non-small cell lung cancer stage IIIA+1

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Universita' Degli Studi Di Torino

Genitourinary tract neoplasm

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Niraparib Tosilate Monohydrate
  • Sponsor:Universita' Degli Studi Di Torino

Non-small cell lung cancer+1

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Universita' Degli Studi Di Torino

Plasma cell myeloma

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Universita' Degli Studi Di Torino

Plasma cell myeloma

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Universita' Degli Studi Di Torino

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.